Home
Product Candidate
Eniluracil: Background
Eniluracil: Clinical Development
Eniluracil: Market Opportunity
Eniluracil: Mechanism of Action
About
Board of Directors
Management Team
Consultants
Principal Investigator
Careers
Investors & Media
Annual Reports and Meetings
Events
Presentations
SEC Filings
Corporate Governance
Sedar Filings
Clinical Trials
AHX-03-202: Metastatic Breast Cancer
Collaborations
Contact Us
Adherex
Providing innovative therapies that improve the life of cancer patients
Our Purpose
Provide innovative therapies that improve the life of cancer patients.
Click to view “The Eniluracil Story” presentation:
Recent News
Adherex Reports Feedback From the FDA From End of Phase 2 Meeting
May 24, 2013
Adherex Reports Recent Developments and First Quarter March 31, 2013 Financial Results
May 13, 2013
Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2012 Financial Results
April 1, 2013
> Read All News
